Ally Bridge Participates in Funding of Beijing's LinkDoc Technology

Ally Bridge Group of Hong Kong and San Francisco participated in the Series B funding of LinkDoc Technology, a Beijing company that is gathering medical records from cancer patients. Using the records, LincDoc will offer doctors evidence-based best practices for personalized medicine, and it will allow pharmaceutical companies to access the database for drug development and marketing. Financial details were not disclosed. More details.... Share this with colleagues: // //